Frontlight ResearchEarly access
Taking people in United StatesNo phase
Imaging Small Lung Biopsy Samples to Check Lung Disease
Tests imaging of small lung biopsies in adults with lung cancer or sarcoidosis.
Key facts
- Who runs it
- Johns Hopkins University
- Where
- Baltimore, United StatesSee the site
- Trial code
- Registry title
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 9 Dec 2021
- Expected to end
- 8 Dec 2026
- Type of study
- Observational
- Treatments tested
- Full-field optical coherence tomography
- Record updated
- 17 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are having a bronchoscopy for diagnosis or staging and who are giving small biopsy samples as part of their normal care.
- Age
- 18 years or older
- Sex
- All sexes can join
Main reasons for not taking part
- Standard reasons that make bronchoscopy unsafe, such as bleeding disorders
- Taking antiplatelet or anticoagulant medicine
- Severe respiratory failure
- Clinical instability
- Pregnancy
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Inpatients or outpatients greater than or equal to 18 years old
- Capable of providing informed consent
- Undergoing bronchoscopy for diagnosis or staging per standard of care
- Collection of small biopsy samples by EBUS or conventional transbronchial needle aspiration (TBNA) or transbronchial biopsy for purposes outside of the research study
Who cannot take part
- Standard contraindications bronchoscopy including bleeding disorders, antiplatelet or anticoagulant usage, severe respiratory failure, and clinical instability
- Pregnancy
Where in United States
- Johns Hopkins HospitalBaltimore, United StatesContact: IP Research TeamTaking people
About the trial
What the trial wants to find out
This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard histologic evaluation.
Treatments tested
- Full-field optical coherence tomography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
- Plain-language title
- Imaging Small Lung Biopsy Samples to Check Lung DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 December 2025